Clinical consequences of switching from olanzapine to risperidone and viceversa in outpatients with schizophrenia: 36-months results from the Worldwide Schizophrenia Outpatients Health Outcomes (W-SOHO) study

被引：0
|
作者：
Novick, D. [1 ]
Hong, J. [1 ]
Brugnoli, R. [2 ]
Karagianis, J. [3 ]
Dossenbach, M. [4 ]
Haro, J. M. [5 ]
机构：
[1] Eli Lilly & Co, Windlesham, Surrey, England
[2] Eli Lilly & Co, Rome, Italy
[3] Eli Lilly & Co, Toronto, ON, Canada
[4] Eli Lilly & Co, Vienna, Austria
[5] Eli Lilly & Co, Barcelona, Spain
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2010年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：230 / 230
页数：1
相关论文
共 50 条
  • [1] Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
    Jihyung Hong
    Diego Novick
    Roberto Brugnoli
    Jamie Karagianis
    Martin Dossenbach
    Josep Maria Haro
    [J]. BMC Psychiatry, 12
  • [2] Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
    Hong, Jihyung
    Novick, Diego
    Brugnoli, Roberto
    Karagianis, Jamie
    Dossenbach, Martin
    Haro, Josep Maria
    [J]. BMC PSYCHIATRY, 2012, 12
  • [3] Factors associated with remission in schizophrenia: 36-months results from the French cohort of the schizophrenia outpatients health outcomes (SOHO) study
    Gasquet, Isabelle
    Avoinet, Sandra
    Chartier, Florence
    Tcherny-Lessenot, Stephanie
    Lepine, Jean-Pierre
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S159 - S160
  • [4] Effectiveness of different doses of olanzapine in outpatients with schizophrenia: 36-month results from the schizophrenia outpatients health outcomes (SOHO) study
    Novick, D.
    Deberdt, W.
    Haro, J. M.
    Suarez, D.
    Guerreiro, M.
    Laranjeira, L.
    Edlund, C.
    Marques-Teixeira, J.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S280 - S280
  • [5] Frequency of response and relapse across different geographical regions: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
    Novick, D.
    Haro, J. M.
    Brugnoli, R.
    Jordan, B.
    Hong, J.
    Jamie, K.
    Dossenbach, M.
    Alvarez, E.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 231 - 231
  • [6] ADHERENCE WITH ANTIPSYCHOTIC TREATMENT MEDICATION IN OUTPATIENTS WITH SCHIZOPHRENIA: 36-MONTH RESULTS FROM THE SCHIZOPHRENIA OUTPATIENTS HEALTH OUTCOMES (SOHO) STUDY
    Novick, D.
    Suarez, D.
    Haro, J. M.
    Haddad, P. M.
    [J]. EUROPEAN PSYCHIATRY, 2009, 24
  • [7] Clinical consequences of switching antipsychotic drugs in outpatients with schizophrenia: 36-month results from the European Schizophrenia Outpatient Health Outcomes study
    Novick, Diego
    Maria Haro, Josep
    Suarez, David
    Marques-Teixeira, Joao
    Naber, Dieter
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (04) : 203 - 208
  • [8] Factors associated to risk of relapse in schizophrenia: 36 month results from the schizophrenia outpatients health outcomes (SOHO) study
    Novick, D
    Haro, JM
    Suarez, D
    Ratcliffe, M
    [J]. SCHIZOPHRENIA RESEARCH, 2006, 81 : 60 - 60
  • [9] Factors associated with remission in schizophrenia: 36-month results from the schizophrenia outpatients health outcomes (SOHO) study
    Novick, D
    Haro, JM
    Slooff, C
    Suarez, D
    Kennedy, L
    Boomsma, M
    Brown, J
    Lepine, JP
    [J]. SCHIZOPHRENIA RESEARCH, 2006, 81 : 61 - 61
  • [10] Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: Results from the European Schizophrenia Outpatients Health Outcomes (SOHO) study
    Novick, D
    Bousono, M
    Suarez, D
    Olivares, JM
    Montejo, AL
    Haro, JM
    Edgell, ET
    Ratcliffe, M
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (06): : 970 - 980
12345